Mode
Text Size
Log in / Sign up

Retinal microvascular features associated with subclinical cardiovascular dysfunction in type 2 diabetesYour Eyes Could Warn You About Hidden Heart Trouble

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note associations between retinal microvascular features and subclinical cardiovascular dysfunction in type 2 diabetes.

This cross-sectional study included 182 participants considered for inclusion, of whom 128 participants (70%) had eligible retinal images. The exposure involved retinal microvascular features (RVFs) quantified by an AI-enabled tool (QUARTZ). The primary outcome assessed associations between these RVFs and measures of subclinical cardiovascular dysfunction derived from CMR imaging. No medications were evaluated in this analysis.

Specific associations were identified between venular tortuosity and left ventricular (LV) T2 mean, which was 0.5ms greater per 1-SD increase in venular tortuosity. Venular tortuosity was also associated with LV global longitudinal strain, showing 0.6% worsening per 1-SD increase in venular tortuosity. Additionally, left atrial max volume was 2 mL greater per 1-SD increase in venular tortuosity.

Arteriolar calibre uniformity and venular area were associated with LV T1 mean, which was 9ms lower per 1-SD increase in these features. Venular area was associated with proximal descending aortic distensibility, which was 0.2x10^-3mmHg^-1 greater per 1-SD increase in venular area. Safety data, adverse events, and discontinuations were not reported in this observational analysis.

The study limitations include its cross-sectional design, which precludes causal inference. Associations were examined rather than established causality. Five RVF-CMR associations remained significant after adjustment for confounders. This evidence supports the potential role of retinal imaging in evaluating cardiovascular dysfunction prior to overt disease in this population.

BODY

You go to the eye doctor every year. You check your vision and eye pressure. But what if that visit could also check your heart?

Heart disease is a major risk for people with diabetes. Often, damage happens silently without pain. Doctors usually wait for symptoms before testing the heart.

Many patients feel frustrated by this delay. They want to know risks before they become serious. Early detection is the key to better health.

Why look at the eyes?

The blood vessels in your eye are like tiny windows. They show what is happening inside your body. If these vessels look bad, the heart might be struggling too.

These vessels are very small and delicate. They react to changes in blood flow quickly. This makes them a perfect place to look for trouble.

The surprising shift in science

We used to think eye health and heart health were separate. This study links them directly. It shows that eye changes match heart changes.

Doctors often treat the eyes and the heart as different systems. Now, we see they share the same blood supply. Damage in one place often shows in the other.

How the body connects vessels

Think of your blood vessels as a plumbing system. If the pipes in your eye get twisted, the pipes in your heart might be too. This new research uses AI to measure those twists.

The AI tool acts like a digital magnifying glass. It finds tiny details that human eyes might miss. This helps doctors see patterns in the data.

How researchers tested this study

Researchers looked at 128 people with type 2 diabetes. They used special software to scan retinal images. They also used heart MRI scans to measure function.

This was a cross-sectional study. It looked at data at one specific point in time. They compared the eye images to the heart scans.

What the data showed clearly

They found specific patterns in the veins. Twisted veins linked to heart muscle strain. This means the heart was working harder than it should.

Some vessels showed changes in width and shape. These changes matched up with heart tissue issues. It suggests the heart is under stress early on.

This doesn’t mean this treatment is available yet.

What experts say about this

Experts call this a non-invasive window into health. It avoids needles or heavy radiation. It offers a safer way to monitor risk.

This approach could save lives by catching issues early. It reduces the need for more invasive tests. Patients might feel more comfortable with eye exams.

You cannot get this test at your optometrist today. It is not a standard part of care. You should keep seeing your heart doctor as usual.

Do not try to interpret your own eye scans. Trust your medical team to guide your care. Keep managing your diabetes with proven methods.

What we still do not know

This was a small group of people. It only looked at those with diabetes. We do not know if it works for everyone.

The study was published as a preprint. This means it has not been peer-reviewed yet. Results could change with more scientific scrutiny.

What happens next for patients

More research is needed to confirm these results. Scientists must test this on larger groups. Approval for clinics will take time.

Future studies will check if this helps prevent disease. It might become a standard screening tool one day. For now, it remains a promising scientific finding.

Study Details

Study typeCohort
Sample sizen = 182
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Aims Microvascular dysfunction is implicated in the pathogenesis of many cardiovascular (CV) diseases, with retinal imaging providing a non-invasive window into microvascular health. Prior evidence links retinal microvascular features (RVF) with cardiac structure and function, yet these relationships remain incompletely characterised. This study systematically examined associations between RVFs and measures of subclinical CV dysfunction derived from CMR imaging. Methods and results 182 participants with type 2 diabetes were considered for inclusion in this cross-sectional study. Fifteen CMR measures of cardiac structure, function, tissue characterisation, adiposity, and aortic distensibility were derived. 128 participants (70%) had eligible retinal images. An artificial intelligence (AI)-enabled retinal image analysis tool (QUARTZ) quantified eight RVFs: arteriolar and venular diameter, area, calibre uniformity, and tortuosity. Multivariable regression examined RVF-CMR associations, expressed as change in CMR measures per 1-standard deviation (SD) increase in RVF. Five RVF-CMR associations remained significant after adjustment for confounders. Venular tortuosity was associated with a 0.5ms greater left ventricular (LV) T2 mean, 0.6% worsening in LV global longitudinal strain, and a 2 mL greater left atrial max volume. Arteriolar calibre uniformity and venular area were each associated with 9ms lower LV T1 mean and 0.2x10-3mmHg-1 greater proximal descending aortic distensibility, respectively. Conclusion In a diabetic cohort, we identified novel and biologically coherent associations between RVF and CMR measures. Notably, venular tortuosity was associated with a constellation of CMR changes consistent with subclinical myocardial dysfunction. These findings support the potential role of retinal imaging in evaluating CV dysfunction prior to overt disease.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.